Assessing the role of ICD in Chagas heart disease: a systematic review, meta-analysis, and meta-regression
- PMID: 40924256
- DOI: 10.1007/s10840-025-02109-5
Assessing the role of ICD in Chagas heart disease: a systematic review, meta-analysis, and meta-regression
Abstract
Background: Chagas heart disease (ChD) is a significant public health concern in Latin America, contributing to a high incidence of sudden cardiac death (SCD). Despite advances in heart failure treatment, management of Chagas cardiomyopathy has not progressed accordingly. While ICDs are effective for primary and secondary prevention in other conditions, patients with ChD often experience more frequent episodes of ventricular tachycardia, and ICD use may provide a negative impact and increase mortality. This meta-analysis focuses on ICD use in ChD patients, providing a comparative analysis with other etiologies.
Methods: We systematically searched PubMed, Embase, and Cochrane databases for studies evaluating ICD use in ChD. We pooled event prevalence for single-arm analyses and calculated risk ratios (RR) for pairwise comparisons with non-ChD, using a random effects model with 95% confidence intervals (CI). Statistical analyses were conducted using R version 4.4.3.
Results: Twenty-three studies were included, comprising a pooled population of 2833 patients, with 1679 (59.2%) diagnosed with ChD. The ACM rate was 22.59% (95% CI 17.09 to 29.25). Notably, the appropriate intervention rate was 58.50% (95% CI 50.06 to 66.29), with ChD patients showing a higher incidence compared to non-ChD (RR 1.61; 95% CI 1.13 to 2.29; p < 0.01; I2 = 63%). Inappropriate therapy occurred in 7.64% (95% CI 4.98 to 11.54) of cases, while electrical storms were reported in 23.49% (95% CI 13.88 to 36.89) of ChD patients.
Conclusion: Overall, although ICDs can be a viable option that offers therapeutic benefits, their use in ChD patients requires careful evaluation to optimize clinical outcomes.
Keywords: Chagas heart disease; Implantable-cardioverter defibrillator; Meta-analysis; Mortality; Shock.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: All authors report no relationships that could be construed as a conflict of interest. All authors take responsibility for all aspects of the reliability and freedom from bias of the presented data and their discussed interpretation.
References
-
- Oliveira GMMde, Brant LCC, Polanczyk CA, Biolo A, Nascimento BR, Malta DC, …, Ribeiro ALP. Cardiovascular statistics - Brazil 2020. Arq Bras Cardiol. 2020;115(3):308–439. https://doi.org/10.36660/abc.20200812 .
-
- Braggion-Santos MF, Volpe GJ, Pazin-Filho A, Maciel BC, Marin-Neto JA, Schmidt A. Sudden cardiac death in Brazil: a community-based autopsy series (2006–2010). Arq Bras Cardiol. 2014;104(2):120–7. https://doi.org/10.5935/abc.20140178 . - DOI - PubMed
-
- Rassi AJ, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arq Bras Cardiol. 2001;76(1):75–96. https://doi.org/10.1590/s0066-782x2001000100008 . - DOI - PubMed
-
- Nadruz WJ, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, Fernandes-Silva MM, Silvestre OM, …, Pereira AC. Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure. Heart (Br Cardiac Soc). 2018;104(18):1522–1528. https://doi.org/10.1136/heartjnl-2017-312869 .
-
- Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, …, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21(24):2071–2078. https://doi.org/10.1053/euhj.2000.2476 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
